Sex: M
Vaccine: HIBV, MMR, PNC13, UNK
Symptoms: Decreased appetite, Gait disturbance, Gait inability, Irritability
Clinical narrative: Couldnt walk for hours; Would stumble when he did walk again; Loss of appetite even to this day; fussiness to this day; Initial information regarding an unsolicited valid non-serious case downloaded from the VAERS database received on 29-Mar-2019 from Other health care professional via Health Authorities under reference 738053-1.  This case involves a 12 months old male patient who experienced couldnt walk for hours, would stumble when he did walk again, loss of appetite even to this day and fussiness to this day, while he received vaccines VARIVAX [VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK)], PREVNAR 13, MMR II and HAEMOPHILUS TYPE B (HIB) VACCINE.  The patients past medical history, concomitant medication and family history were not provided.   On 13-Feb-2018, the patient received injection of suspect HAEMOPHILUS TYPE B (HIB) VACCINE produced by unknown manufacturer lot number not reported via unknown route LG. On 13-Feb-2018, the patient received injection of suspect PREVNAR 13 not produced by Sanofi Pasteur lot number not reported via unknown route in LG. On 13-Feb-2018, the patient received injection of suspect VARIVAX [VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK)] not produced by Sanofi Pasteur lot number not reported via unknown route LG. On 13-Feb-2018, the patient received injection of suspect MMR II not produced by Sanofi Pasteur lot number not reported via unknown route in right leg.  On 13-Feb-2018, the patient developed a non-serious couldnt walk for hours (gait disturbance) same day following the administration of HAEMOPHILUS TYPE B (HIB) VACCINE, following the administration of MMR II, following the administration of PREVNAR 13 and following the administration of VARIVAX [VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK)]. On 13-Feb-2018, the patient developed a non-serious would stumble when he did walk again (gait inability) same day following the administration of HAEMOPHILUS TYPE B (HIB) VACCINE, following the administration of MMR II, following the administration of PREVNAR 13 and following the administration of VARIVAX [VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK)]. On 13-Feb-2018, the patient developed a non-serious loss of appetite even to this day (decreased appetite) same day following the administration of HAEMOPHILUS TYPE B (HIB) VACCINE, following the administration of MMR II, following the administration of PREVNAR 13 and following the administration of VARIVAX [VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK)]. On 13-Feb-2018, the patient developed a non-serious fussiness to this day (irritability) same day following the administration of HAEMOPHILUS TYPE B (HIB) VACCINE, following the administration of MMR II, following the administration of PREVNAR 13 and following the administration of VARIVAX [VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK)].  Lab data was not provided.  Final diagnosis was fussiness to this day, loss of appetite even to this day, would stumble when he did walk again and couldnt walk for hours.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for couldnt walk for hours, as Unknown for would stumble when he did walk again, as Unknown for loss of appetite even to this day and as Unknown for fussiness to this day.  List of documents held by sender- none.